Dermatology


Showing 71-80 of 87 Results

  • Dawn H. Siegel, MD

    Dawn H. Siegel, MD

    Clinical Professor, Dermatology
    Clinical Professor (By courtesy), Pediatrics

    Current Research and Scholarly InterestsI'm dedicated to connecting patients with clinical research trials and contributing to research on specific skin conditions particularly hemangiomas, birthmarks, and PHACE syndrome. My research also aims to develop solutions to health disparities through improved access to pediatric dermatologists and treatments.

  • John B. Sunwoo, MD

    John B. Sunwoo, MD

    Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology

    Current Research and Scholarly InterestsMy laboratory is focused on two primary areas of research: (1) the immune response to head and neck cancer and to a tumorigenic population of cells within these malignancies called cancer stem cells; (2) the developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells; and (3) intra-tumor and inter-tumor heterogeneity.

  • Susan M. Swetter, MD

    Susan M. Swetter, MD

    Professor of Dermatology

    Current Research and Scholarly Interests1) Early detection of melanoma through enhanced screening, novel imaging technologies, and professional/public education to improve melanoma awareness. 2) Therapeutic prevention of melanoma and other skin cancers in high-risk groups. 4) Epidemiologic and sociodemographic melanoma risk factors. 4) Dermatologist liaison to ECOG-ACRIN Melanoma Committee and Co-founder/Co-Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control.

  • Jean Y. Tang MD PhD

    Jean Y. Tang MD PhD

    Professor of Dermatology
    On Partial Leave from 05/01/2026 To 04/30/2027

    Current Research and Scholarly InterestsMy research focuses on 2 main areas:

    1. Skin cancer:
    - New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
    - Genomic analysis of drug-resistant cancers
    - Identifying risk factors for skin cancer in the Women's Health Initiative

    2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB

  • Joyce Teng, MD, PhD

    Joyce Teng, MD, PhD

    Professor of Dermatology and, by courtesy, of Pediatrics

    BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.

  • Chen Wang, MD, PhD

    Chen Wang, MD, PhD

    Clinical Assistant Professor, Dermatology

    BioDr. Wang is a board-certified dermatologist with the Stanford Dermatology Clinic and a clinical assistant professor in the Department of Dermatology at Stanford University School of Medicine.

    Dr. Wang specializes in medical dermatology. He commonly diagnoses and treats conditions such as acne, inflammatory skin diseases, hair loss, and skin cancer.

    Dr. Wang completed a postdoctoral fellowship in immunology research with the Mark M. Davis Laboratory at Stanford University. His research interests include cutaneous immunology and the role of T cells in inflammatory skin diseases.

  • Jennifer Y. Wang, MD

    Jennifer Y. Wang, MD

    Clinical Assistant Professor, Dermatology

    BioDr. Wang is a board-certified dermatologist. She is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Wang is also board-certified in dermatopathology.

    Her clinical interests include medical dermatology and cutaneous oncology, including melanoma, high-risk skin cancer, and cutaneous lymphoma. Her research interests include the histopathologic characterization of rare skin disorders and improving the detection and treatment of skin cancers.